Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WST03 Combined With Metronidazole for Bacterial Vaginosis
NCT07888699Phase 2Not yet recruiting
- Sponsor
- SPH Sine Pharmaceutical Laboratories
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of WST03 in bacterial vaginosis (BV), sponsored by SPH Sine Pharmaceutical Laboratories. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
WST03
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT07888699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07888699.